A large body of evidence shows that during the transition into stationary phase, bacteria acquire numerous new physiological properties which enhance their ability to compete and survive under suboptimal conditions (for reviews, see references 16, 25, 26, and 44) . While it has become clear that in Escherichia coli the induction of several genes and operons in the stationary phase requires a putative sigma factor, katF or rpoS (2, 20, 25, 41) , the expression of stationaryphase genes such as mcbA for microcin production (2) and glgCA for glycogen synthesis do not require katF (13, 38a) , suggesting that additional regulators exist. We have initiated studies to identify and characterize factors that control the glycogen biosynthesis genes in E. coli. Our previous experiments showed that cyclic AMP (cAMP), cAMP receptor protein, and guanosine 3'-bisphosphate 5'-bisphosphate (ppGpp) stimulate the expression of the genes for the essential enzymes of the glycogen pathway, glgC (encoding ADPglucose pyrophosphorylase [EC 2.7.7.27]) and glgA (encoding glycogen synthase [EC 2.4.1.21]) (34, 38) , which are apparently cotranscribed in an operon, glgCAY. This operon also includes the gene encoding the catabolic enzyme glycogen phosphorylase (EC 2.4.1.1), glgY or glgP (36, 53 (36) . Although the expression of the three biosynthetic genes is induced in stationary phase, glgB is transcribed independently ofglgCA and it is not regulated by * Corresponding author.
cAMP-cAMP receptor protein or ppGpp (32, 38) . Four stationary-phase-induced transcripts have been mapped within the 0.5-kb upstream noncoding region of the glgC gene from E. coli, implying complex transcriptional regulation of glgCA (38) .
The present paper describes the identification and molecular characterization of a gene from E. coli K-12, csrA, that negatively regulates the expression of both glgC and glgB. The cloning, nucleotide sequencing, and in vitro expression of csrA and some of the regulatory effects of a csrA mutation are presented. Genetic and physical mapping experiments which showed that csrA is located between the alaS and serV genes at 2,834.8 kb on the physical map of the E. coli K-12 genome are reported elsewhere (35) . The csrA mutation is pleiotropic, suggesting that csrA encodes a global regulatory factor.
The discovery of csrA reemphasizes that the synthesis of glycogen in E. coli is controlled in response to a variety of genetic and physiological influences. This is also reflected in the array of trans-acting factors that regulate glgCA expression, in the complex transcription pattern observed for glgC (38) , the allosteric regulation of ADPglucose pyrophosphorylase activity (for a review, see references 30 and 32) , and the effects of katF and glgS on glycogen synthesis via mechanisms that are still unknown (13, 20) .
MATERIALS AND METHODS
Chemicals and reagents. Radioisotopically labeled 32ppi (2.1 mCi/4umol), ot-35S-dATP (1, 200 (36, 38) . Polymerase chain reaction (PCR) was conducted by the asymmetric synthesis method (11) . Deletion mutants of pCSR10 were constructed according to the method described by Henikoff (14) . Nucleotide sequencing was by the dideoxynucleotide chain termination method (40) . For (50) . Transduction of the TR1-5 (csrA::kanR) mutation was conducted by using Plvir according to the method described by Miller (27) (31) .
S-30-coupled transcription translation. The expression of plasmid-encoded genes in S-30 extracts and the analysis of the in vitro-synthesized proteins were conducted as previously described (38) . Proteins were labeled with [35S]methionine, separated on 10 to 22% gradient sodium dodecyl sulfate (SDS)-polyacrylamide slab gels, and detected by fluorography with sodium salicylate (5) .
Nucleotide sequence accession number. The accession number L07596 has been assigned to the sequence shown in Fig.  10 by GenBank, which has been recorded in a data base of E. coli sequences compiled by Rudd et al. (39) .
RESULTS
Isolation of a transposon mutant, TR1-5, that exhibits altered expression of the glycogen biosynthesis genes. To identify the genes that regulate the expression of the gig genes, we mutagenized BW3414(pCZ3-3) with a mini-kanR element (50) . This strain lacks a chromosomal copy of lacZ but contains native chromosomally encoded copies of the gig genes, as well as a plasmid-encoded glgC'-'lacZ translational fusion. The expression of this glgC'-'lacZ fusion is controlled by all of the factors that are known to regulate the native glgC gene (34) . Cells were plated onto Kornberg medium containing kanamycin and ampicillin, the plates were incubated overnight at 370C, and glycogen synthesis mutants were identified by staining with iodine vapor (36).
3-Galactosidase activities in mutants which exhibited either increased or decreased iodine staining were determined. Approximately 15,000 Kanr mutants were generated, and 3-galactosidase activity was determined for 47 glycogen mutants. The TR1-5 mutant exhibited intense iodine staining and five-to sixfold higher 13-galactosidase activity than the parent strain, although four other glycogen excess, glgC'-'lacZ-overexpressing mutants which showed less dramatic effects were isolated. The transposon which was used was expected to generate stable mutations (50) , and the TR1-5 mutant was found to be phenotypically stable during extensive growth experiments, indicating that second-site reversions do not present a problem in handling this strain.
The TR1-5 mutation alters glycogen biosynthesis via effects on the expression of two glycogen biosynthetic operons. The extremely intense staining of colonies of the TR1-5 mutant indicated that glycogen levels were much higher than in the parent strain. The TR1-5 mutation was transduced into BW3414 to generate a mutant strain that did not carry the pCZ3-3 plasmid and to provide a genetic background which had not been subjected to transposon mutagenesis. Glycogen levels were quantitatively determined in the mutant TR1-5BW3414 and wild-type BW3414 strains and were compared (Table 2 ). TR1-5BW3414 accumulated 20-to 30-fold more glycogen than the parent strain, consistent with the qualitative results of iodine staining. Levels of ADPglucose pyrophosphorylase were found to be significantly higher in the TR1-5 mutant than in an isogenic wild-type strain, in both the exponential and stationary phases of growth, with the maximal difference of almost 10-fold occurring in the stationary phase ( Table 2 ).
The specific activity of 3-galactosidase expressed from the glgC'-'lacZ fusion was monitored throughout the exponential and stationary phases of wild-type and TR1-5 mutant strains. The TR1-5 mutant overexpressed this gene fusion in both the exponential and stationary phases ( Fig. 1 ). It was observed that specific 3-galactosidase activity was sevenfold higher in stationary phase (24 h) versus mid-log phase in both mutant and wild-type strains and that a change of approxi- The TR1-5 mutation affects glycogen biosynthesis independently of cAMP and ppGpp. The observation that gigE expression was elevated in the TR1-5 mutant suggested that its effect on glycogen levels was not mediated indirectly via cAMP or ppGpp, which have been shown not to regulate glgB (34, 38) . To directly test this idea, the TR1-5 mutation was transduced into several strains that were deficient in one or more of the genes needed for cAMP or ppGpp control. The TR1-5 mutation resulted in enhanced glycogen levels in cAMP-deficient (Acya) and in cAMP receptor protein-deficient (ctp) strains (Fig. 3) and in strains that accumulate low levels of ppGpp (ArelA) or are completely deficient in ppGpp (AreIAespoT; Fig. 4 (9) . The TR1-5 mutation was transduced into HG137, a strain containing a chromosomally encoded pck-lacZ operon fusion (9) . The specific P-galactosidase activity from this gene fusion was twofold higher in the TR1-5 mutant than in the isogenic wild-type parent. The induction curve in the mutant paralleled that of the wild-type strain (Fig. 5) .
Effects of the TR1-5 mutation on cell morphology. It was observed that the maximum turbidity of liquid cultures of strains containing the TR1-5 mutation was higher than that of isogenic wild-type strains in Kornberg medium (Fig. 1, 2 (Fig. 8) The nucleotide sequence determined from pTR151 ( Fig. 9  and 10 ) and subclones derived from this plasmid was used to search the EMBL and GenBank data bases for homologous genes. This search showed that the Kanr marker had been inserted downstream from alaS, which encodes alanine tRNA synthetase (33) . None of the Kanr plasmid clones that were isolated contained csrA DNA from the side of the marker opposite alaS. Attempts to subclone the entire region of the native csrA gene directly from a bacteriophage X clone (X446 of the Kohara miniset [15] ) into pUC19 or pLG339 were unsuccessful, although numerous plasmid clones containing restriction fragments that originated near this region were isolated. Two of these clones, pPV1 and pLEP2-2 ( Fig. 9) , were partially sequenced and were found to contain part of the serVoperon of tRNA genes (17) . These sequence data and the restriction map of E. coli K-12 (39) indicated that approximately 0.2 kb of DNA sequence remained undetermined on the counterclockwise side of the Kanr marker, i.e., between serV and the kanR gene. Each strand of DNA in this region was individually amplified from X446 DNA by asymmetric PCR (11) and was sequenced directly from the PCR products. Thus, the nucleotide sequence of both strands of the 0.7-kb gap separating the alaS and serV genes on the E. coli K-12 chromosome was (Fig. 10) . This was the only ORF in this region that was preceded by sequence motifs that are characteristic of a ribosome-binding site (43) , and it displayed a consensus sequence in the initiation codon-distal region that is typical of genes that are translated in E. coli (29) . The transposition site is located at codon 51 of this ORF. There is no obvious rho-independent terminator sequence for this proposed gene (Fig. 10) , although a potential stem and loop structure was found immediately following alaS. Computer-assisted searches with the nucleotide sequence of this ORF or the deduced amino acid sequence of its proposed gene product failed to identify homologous genes, proteins, or procaryotic sequence motifs. The deduced amino acid sequence of the ORF contained no cysteine, phenylalanine, or tryptophan. Analysis of this amino acid sequence to predict hydrophobicity (19) indicated that the N-terminal half of the proposed product is relatively hydrophobic and is followed by a relatively hydrophilic C-terminal region (data not shown).
Since the inspection of clonable versus unclonable fragments in the region of csrA (Fig. 9) suggested that an element in the region of the serV promoter, perhaps the promoter itself, was not amenable to plasmid cloning, a 0.53-kb DdeI restriction fragment that avoided the intact serV promoter ( Fig. 9 and 10 (17), and an inverted repeat sequence immediately downstream from alaS are underlined. The nucleotides 283 to 286 are complementary to nucleotides near the 5' terminus of E. coli 16S RNA and fulfill the criteria described by Petersen et al. (29) for sequences which are expected to be found within the initiation codon-distal region of expressed genes. An arrow marks the site of the TR1-5 insertion mutation, which is between 421 and 422 bp. The DdeI sites used in subcloning csrA into pUC19 to generate pCSR10 are located at 168 and 698 bp.
region was isolated from X446, made blunt ended with the Klenow fragment, and subcloned into the SmaI site of pUC19 to generate pCSR10. Transformation of the glycogen-overproducing mutant TR1-5BW3414 with pCSR10 has a dramatic effect on glycogen accumulation (Fig. 11) . A variety of E. coli strains have been transformed with the plasmid pCSR10, and in all cases the transformants have been found to be deficient in glycogen. These results suggest that pCSR10 contains the functional csrA gene. Complementation and in vitro expression studies of csrA: evidence that csrA encodes a 61-amino-acid polypeptide that inhibits glycogen biosynthesis. Several deletion derivatives of pCSR10 were constructed and sequenced to allow analysis of the proposed csrA coding region (Fig. 12) . A 57-bp deletion that is positioned 94 bp downstream from the coding region did not affect the ability of plasmid pCSR-L1 to complement the TR1-5 mutation. A deletion that removed 8 amino acids of the coding region and resulted in the addition of 24 heterologous amino acids had a slight effect on the ability of plasmid pCSR-D1-L to alter the glycogen synthesis phenotype. Finally, two deletions that remove 21 or 16 amino acids from the proposed csrA coding region severely disrupted the ability of plasmids pCSR-D3 and pCSR-Dl-D, respectively, to complement the TR1-5 mutation. These analyses show that disruption of the 3' end of the ORF that was proposed to encode csrA interferes with the effect of these plasmids on the glycogen phenotype. The observation that removing 8 amino acids of the coding region only FIG. 11 . pCSR10 strongly inhibits glycogen biosynthesis in vivo. Cultures were streaked onto Kornberg medium and incubated overnight at 37C before staining with iodine. BW, BW3414; TRBW, TR1-5BW3414.
partially inactivates csrA in a multicopy plasmid allows that a partially active product could also be produced from the TR1-5 mutant allele (an insertion at codon 51). In the latter case, the negative effect of the mutant gene product on glycogen synthesis may be minimal or negligible, since it should be expressed at a much lower level.
The proteins encoded by pUC19, pCSR10, and two of the deletion derivatives that alter the proposed coding region of csrA were analyzed in vitro in S-30-coupled transcription translation reactions (Fig. 12C) . pCSR10 encoded only a single polypeptide that was not observed in the reaction with pUC19 as a template (Fig. 12C and data not shown) . This polypeptide was strongly expressed in vitro and exhibited a mobility on SDS-polyacrylamide gel electrophoresis that was consistent with the molecular mass of the proposed csrA gene product, 6.8 kDa. One of the deletions (present in pCSR-D1-L) resulted in a net change of +16 amino acids in the coding region, and the second (pCSR-D1-D) resulted in a net change of -12 amino acids. The pUC19-independent (insert-specific) proteins that were expressed from these deletion derivatives were detected in significantly lower levels than the insert-specific protein expressed from pCSR10, making interpretations about these deletions less than definitive. However, insert-specific proteins consistent with an increase (pCSR-D1-L) or a decrease (pCSR-D1-D) in gene product size, predicted by ORF analysis, were weakly detectable, suggesting that the observed 183-bp ORF encodes the native csrA gene product. The poor expression of the two deletion derivatives could be due to effects of the deletions on transcript or protein stability. Alternatively, one or more regulatory sites for csrA expression may be located distal to the csrA-coding region.
Taken together, these experiments provided both structural and functional evidence indicating that the proposed 183-bp ORF represents the csrA coding region and that the regulatory effects of csrA on glycogen biosynthesis are mediated via its 61-amino-acid gene product. prop- erties that were at least as distinct as (or probably more so than those of colonies grown aerobically, i.e., the mutant stained dark brown within seconds, whereas the wild-type and pCSR10-containing strains only stained yellow over 2 or more min of exposure to iodine vapor (data not shown). This suggested that csrA-mediated regulation of glycogen synthesis is important under both aerobic and anaerobic conditions.
Under aerobic conditions on a rich defined medium, supplemented MOPS medium, the TR1-5 mutation (in the BW3414 genetic background) resulted in enhanced iodine staining on glucose, fructose, and glycerol. Glycogen levels were negligible, as indicated by yellow staining with iodine, when the TR1-5 mutant and csrA+ strains were grown on acetate or succinate (data not shown).
Surprisingly, the pCSR10-containing strain grew as pinpoint colonies on MOPS medium when sodium succinate was added as the major carbon source, although it grew well on all other carbon sources tested, including sodium acetate. The wild-type (BW3414), TR1-5 mutant, and pUC19-containing strains grew well on sodium succinate (data not shown). This suggests that overexpression of csrA results in a specific defect in the ability of cells to utilize succinate as a carbon source.
When wild-type, TR1-5, and pCSR10-or pUC19-containing strains (in the CF1648 genetic background) were streaked onto M9 minimal medium, it was found that the pCSR10-containing strain was unable to grow on any gluconeogenic substrates that were tested, including succinate, glycerol, encoding ADPglucose pyrophosphorylase, glycogen synthase, and glycogen branching enzyme, respectively. Evidence for a third level of control is suggested by the isolation of a class of genes that enhance endogenous glycogen but do not affect glgC expression (37) and by the identification of gigS, a gene that is stimulatory for glycogen accumulation and is transcribed via the putative sigma factor katF or rpoS but whose biochemical mechanism remains unknown (13) . The discovery of gigS partially accounts for the positive effect of katF on glycogen accumulation, since katF is not required for glgCA expression (13, 20) . The present study provides evidence that glycogen synthesis is negatively controlled via the effects of the gene product of csrA (CsrA) on the expression of the operons glgCAY(P) and glgBX. A csrA::kanR transposon insertion increased the expression of glgC and glgB; however, it did not temporally alter the induction or change the shape of the induction curves for these genes, suggesting that csrA functions in addition to the factors that mediate the growth phase response.
The discovery of csrA identifies a third system for the regulation of glycogen biosynthesis via glgCA expression. It contrasts with the other two systems (cAMP-cAMP receptor protein and ppGpp) which are positive regulators of glgCA (34, 38) and of glycogen synthesis (4, 7, 8, 21, 22, 48) and which do not affect glgB expression. The physiological role provided by these systems may be to establish an intrinsic metabolic capacity for glycogen synthesis in response to nutritional status. The effects of other regulatory factors, such as the allosteric effectors fructose 1,6-bisphosphate and AMP, may be viewed as being superimposed upon this intrinsic metabolic capacity. It should be noted that three regulatory systems have been found not to be involved in gigCA expression, the nitrogen starvation system, mediated by NtrC and NtrA or or54 (32, 38) ; heat shock, mediated by o32 (32) ; and the katF-dependent system (13, 38a) , implying that the effects of csrA are not mediated indirectly via these global systems.
Evidence for a negative factor that regulates glycogen synthesis was previously presented, on the basis of the properties of an E. coli B mutation, glgQ (for a review, see references 30 and 32). The fact that glgQ was identified in E. coli B has hampered its genetic analysis, and glgQ has been neither mapped nor cloned. However, we showed that glgQ regulates the transcription ofglgCA and presented evidence suggesting that its effects were independent of cAMP-cAMP receptor protein and ppGpp (34, 38) . The magnitude of the effects ofglgQ and csrA on glgC expression are similar, and csrA and glgQ both affect the expression of glgB. Unlike csrA, the glgQ mutation does not result in an adherent phenotype, and a rigorous understanding of the relationship of csrA to glgQ awaits further studies.
Two kinds of evidence suggest that csrA is involved in the regulation of gluconeogenesis. The TR1-5 mutation caused twofold overexpression of a pck4-lacZ transcriptional fusion. The csrA mutation did not alter the shape of the pckA4-lacZ induction curve, a response that was similar to that of the gig genes. The plasmid pCSR10, which overexpresses the csrA gene product, as indicated by in vitro expression studies and by its strong inhibitory effect on glycogen synthesis, prevented growth on gluconeogenic substrates in M9 minimal medium. Since pckA was overexpressed in the TR1-5 mutant, the overexpression of csrA in cells containing pCSR10 could be predicted to cause excessive repression of pckA and possibly other gluconeogenic genes, resulting in the failure of pCSR10-containing cells to grow with gluconeogenic substrates on M9 medium. The VOL. 175, 1993 on March 1, 2013 by PENN STATE UNIV http://jb.asm.org/ Downloaded from poor growth of pCSR10-containing cells specifically on succinate as a major carbon source in MOPS-supplemented medium suggests that csrA may affect succinate uptake. These hypotheses will be tested in future studies.
It was surprising to find that csrA affects cell surface properties. Glycogen is an endogenous polymer, and the effect of csrA on adherence is not due to its effect on glycogen synthesis, since transduction of the TR1-5 allele into the glycogen-deficient strain G6MD3 also caused this strain to become adherent (data not shown). However, the surface molecule(s) that promotes adherence in the TR1-5 mutant remains undefined. The adherence to and colonization of surfaces by bacteria with the formation of a biofilm, as observed for TR1-5, is affected by nutrient availability and other environmental conditions and is an alternative strategy for cell survival (for reviews, see references 6 and 24). The physiology of cells within a biofilm is different from that of suspended or pelagic cells, but the physiological significance of the effect of csrA on adherence awaits further study.
The failure to identify homologous genes, proteins, or procaryotic sequence motifs via computer-assisted research presents the intriguing possibility that CsrA is a member of a new class of genetic regulatory factors. The limited regions ofglgC and glgB DNAs that were used in the construction of the 'lacZ translational fusions in this study should contain cis-acting sites for CsrA-mediated regulation of glgC and glgB. Preliminary S1 nuclease mapping experiments suggest that csrA affects glgC transcription, and experiments are in progress to rigorously characterize the effects of csrA on transcripts from both glgC and glgB and to identify the required cis-acting regions. We hope to eventually elucidate the mechanism of genetic regulation via this system. The environmental stimulus for and physiological role of csrA in the control of glycogen biosynthesis also remain as future chapters to be written in this interestingly complex story.
